Trade receivables increased 135.4%
Trade receivables changed +135.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$57,957→$136,4024 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →LUCYW financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital / assets moved 660 bp lower
Working capital / assets changed -660 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
89.87%→83.27%4 prior comparisons
Cash & equivalents decreased 67.8%
Cash & equivalents changed -67.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$7.6M→$2.5M4 prior comparisons
Gross margin moved 2619 bp higher
Gross margin changed +2619 basis points from the comparable as-filed period.
-2.19%→24.00%3 prior comparisons
Revenue increased 74.5%
Revenue changed +74.5% from the comparable as-filed period.
$579,230→$1.0M3 prior comparisons
Total assets decreased 37.4%
Total assets changed -37.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$11.9M→$7.5M4 prior comparisons
Current assets decreased 40.1%
Current assets changed -40.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$11.3M→$6.8M4 prior comparisons
Inventory / revenue moved 11413 bp lower
Inventory / revenue changed -11413 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
289.53%→175.40%3 prior comparisons
Operating cash flow increased 11.9%
Operating cash flow changed +11.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
-$2.1M→-$1.9M4 prior comparisons
Research & development decreased 47.0%
Research & development changed -47.0% from the comparable as-filed period.
$268,224→$142,0933 prior comparisons
Shares outstanding increased 88.2%
Shares outstanding changed +88.2% from the comparable as-filed period. The change ranks at the 43th percentile of 7 prior comparable changes.
4,574,602→8,609,1967 prior comparisons
Cost of revenue increased 29.8%
Cost of revenue changed +29.8% from the comparable as-filed period.
$591,895→$768,0043 prior comparisons
SBC / revenue moved 1011 bp lower
SBC / revenue changed -1011 basis points from the comparable as-filed period.
29.73%→19.63%3 prior comparisons
Receivables / revenue moved 349 bp higher
Receivables / revenue changed +349 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
10.01%→13.50%3 prior comparisons
Working capital decreased 42.0%
Working capital changed -42.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$10.7M→$6.2M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.